Transcode Therapeutics, Inc. · NASDAQ:RNAZ

CK Life Sciences Int'l., (Holdings) Inc. reported a 9.10% stake in Transcode Therapeutics, Inc. (Schedule 13D)

Event Oct 8, 2025 · Filed Oct 16, 2025

CK Life Sciences Int'l., (Holdings) Inc. reported a 9.10% stake in Transcode Therapeutics, Inc., 83,285 shares, with active intent on Oct 8, 2025. Filed Oct 16, 2025 (Schedule 13D).

Stake
9.10%
Shares
83,285
Intent
Active
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
CK Life Sciences Int'l., (Holdings) Inc.9.10%83,285
DEFJ, LLC9.10%83,285

Source

View original at SEC

Related